3D bioprinted muscle and tendon tissues for drug development

Chimia

Volumn 69, Issue 1-2, 2015, Pages 65-67

  Rimann, Markus ^a   Laternser, Sandra ^a   Keller, Hansjörg ^b   Leupin, Olivier ^b   Graf Hausner, Ursula ^a  

^a ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

3D cell culture; Alternative test method; Bioprinting standardization; Drug development; Muscle tendon disease; Specialized well plate

Indexed keywords

NEW DRUG;

ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; DEVICES; FIBROBLAST; HUMAN; MYOBLAST; PHYSIOLOGY; PRINTING; PROCEDURES; RAT; SKELETAL MUSCLE; SYNTHESIS; TENDON; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ANIMALS; CELL CULTURE TECHNIQUES; DRUGS, INVESTIGATIONAL; FIBROBLASTS; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; PRINTING; RATS; TENDONS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84924421492     PISSN: 00094293     EISSN: None     Source Type: Journal    
DOI: 10.2533/chimia.2015.65     Document Type: Note

References (6)

1. M. Y. Emmert, R. W. Hitchcock, S. P. Hoerstrup, Adv. Drug Deliv. Rev. 2014, 69, 254.
2. Y. C. Huang, R. G. Dennis, L. Larkin, K. Baar, J. Appl. Physiol. 2005, 98, 706.
3. H. Vandenburgh, Tissue Eng. Part B Rev. 2010, 16, 55.
4. M. Juhas, G. C. Engelmayr, Jr., A. N. Fontanella, G. M. Palmer, N. Bursac, Proc. Natl. Acad. Sci. USA 2014, 111, 5508.
5. N. R. Martin, S. L. Passey, D. J. Player, A. Khodabukus, R. A. Ferguson, A. P. Sharples, V. Mudera, K. Baar, M. P. Lewis, Biomaterials 2013, 34, 5759.
6. M. Rimann, E. Bono, H. Annaheim, M. Bleisch, U. Graf-Hausner, J. Lab. Automation 2015, doi:1177/221106814567146.